{"url":"https://lda.senate.gov/api/v1/filings/8d805824-67de-4ced-b47a-e37ac7bf362a/","filing_uuid":"8d805824-67de-4ced-b47a-e37ac7bf362a","filing_type":"2TY","filing_type_display":"2nd Quarter - Termination (No Activity)","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8d805824-67de-4ced-b47a-e37ac7bf362a/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Margaret Mann","dt_posted":"2026-07-17T14:40:04-04:00","termination_date":"2026-06-30","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2100 Powell Street","registrant_address_2":"Suite 720","registrant_different_address":false,"registrant_city":"Emeryville","registrant_state":"CA","registrant_zip":"94608","registrant":{"id":401106326,"url":"https://lda.senate.gov/api/v1/registrants/401106326/","house_registrant_id":null,"name":"DYNAVAX TECHNOLOGIES CORP.","description":"Biopharmaceutical company focused on developing and commercializing novel vaccines.","address_1":"2100 Powell Street","address_2":"Suite 900","address_3":null,"address_4":null,"city":"Emeryville","state":"CA","state_display":"California","zip":"94608","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MARGARET MANN","contact_telephone":"+1 773-412-4368","dt_updated":"2026-07-24T15:32:45.634377-04:00"},"client":{"id":212949,"url":"https://lda.senate.gov/api/v1/clients/212949/","client_id":12,"name":"DYNAVAX TECHNOLOGIES CORP.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-11-15"},"lobbying_activities":[],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}